The hERG inhibition at a concentration of 1uM of a drug with the SMILES C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)[C@H](CCC(=O)O)n3cc(C(N)CC(C)C)nn3)CC2)nc(N2CCN(C(=O)[C@H](Cc3cc4ccccc4[nH]3)n3cc(C(N)[C@H](C)CC)nn3)CC2)n1.Cl is 12.858\%.
The {herg_central_at_1uM__names__noun} of a {#drug|compound!} with the {SMILES__description} {SMILES#} is {herg_central_at_1uM#}{herg_central_at_1uM__units}.
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)[C@H](CCC(=O)O)n3cc(C(N)CC(C)C)nn3)CC2)nc(N2CCN(C(=O)[C@H](Cc3cc4ccccc4[nH]3)n3cc(C(N)[C@H](C)CC)nn3)CC2)n1.Cl
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)[C@H](CCC(=O)O)n3cc(C(N)CC(C)C)nn3)CC2)nc(N2CCN(C(=O)[C@H](Cc3cc4ccccc4[nH]3)n3cc(C(N)[C@H](C)CC)nn3)CC2)n1.Cl
(4S)-4-[4-(1-amino-3-methylbutyl)triazol-1-yl]-5-[4-[4-[4-[(2S)-2-[4-[(2R)-1-amino-2-methylbutyl]triazol-1-yl]-3-(1H-indol-2-yl)propanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-5-oxopentanoic acid;hydrochloride